You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同仁堂科技(01666.HK)上半年純利升16.13%至3.15億元
格隆匯 08-18 17:06

格隆匯8月18日丨同仁堂科技(01666.HK)公佈中期業績,截至2021年6月30日止6個月,公司收入為人民幣27.66億元,同比增長23.45%;毛利為人民幣12.49億元,同比增長22.18%;歸屬於公司所有者的利潤為人民幣3.15億元,同比增長16.13%,每股收益為人民幣0.25元。

於報吿期內,集團銷售額超過人民幣500萬元的產品整體數量較上年同期增加一個,其中,銷售額超過人民幣1億元的產品六個;銷售額介於人民幣1000萬元至人民幣1億元之間的產品二十三個;銷售額介於人民幣500萬元至人民幣1000萬元之間的產品十三個。

報吿期內,主導產品金匱腎氣丸、牛黃解毒片、西黃丸等系列產品受益於大品種發展戰略及上半年一系列的推廣活動,銷售額相較去年同期均有所增長。其中,金匱腎氣丸系列銷售額較上年同期增長17.69%、牛黃解毒片系列銷售額較上年同期增長52.90%、西黃丸系列銷售額較上年同期增長17.46%、感冒清熱系列銷售額較上年同期增長11.02%。同時,為積極消化市場存量,公司針對阿膠系列產品持續加大分銷市場及終端市場的開發力度,帶動其銷售額較上年同期有所增長。而六味地黃丸系列及生脈飲系列由於終端產品較為充足,其銷售額較上年同期分別下降14.00%及14.89%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account